PerkinElmer, Inc. Gains China OK For Neonatal Test Analyzer

PerkinElmer, which offers products for human and environmental health, was granted CFDA approval to market a new fully automated analyzing device, the Genetic Screening Processor®, along with a test that screens for congenital hypothyroidism in newborns. PerkinElmer said the GSP instrument is capable of testing for a wide range of prenatal and neonatal disorders using a spot of dried blood from the infant.

Help employers find you! Check out all the jobs and post your resume.

Back to news